India Globalization Capi... Stock Price - IGC

0.44
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
India Globalization Capital Inc IGC AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.01 -2.22% 0.44 0.4116 0.45 0.447 0.45 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,345 321,499 $ 0.4334061 $ 139,340 554,872 0.263 - 2.4688
Last Trade Time Type Quantity Stock Price Currency
20:00:00 814 $ 0.44 USD

India Globalization Capi... Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 17.30M 39.32M $ -1.79M -0.14 - 32.50M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.02M $ - 0.00% - -

more financials information »

India Globalization Capi... News

Loading Messages....

Latest IGC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IGC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.61930.740.41160.56836641,174,364-0.1793-28.95%
1 Month0.490.740.2630.5159133731,714-0.05-10.2%
3 Months0.690.900.2630.5778997502,495-0.25-36.23%
6 Months0.961.08840.2630.6827326423,587-0.52-54.17%
1 Year2.062.46880.2631.25750,877-1.62-78.64%
3 Years0.497514.580.2634.112,063,173-0.0575-11.56%
5 Years0.4214.580.1353.971,227,2370.024.76%

India Globalization Capi... Description

India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. The company has focused on four products that it is preparing for medical trials, Natrinol, Caesafin, Serosapse, and Hyalolex. The company generates revenue from purchase and resale of physical commodities like steel, marble and tiles which are used in infrastructure operations.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.